{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:29:40Z","timestamp":1785367780958,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.urolonc.2025.10.020","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:20:43Z","timestamp":1764246043000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perioperative use of venous thromboembolism prophylaxis following major urologic oncology surgeries: A survey of the Society of Urologic Oncology"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4493-5513","authenticated-orcid":false,"given":"Michelle","family":"Slinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine F.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley Bruce","family":"Malkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinity J.","family":"Bivalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.urolonc.2025.10.020_bib0001","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2141.2010.08206.x","article-title":"Risk factors for venous thrombosis\u2014current understanding from an epidemiological point of view","volume":"149","author":"Lijfering","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.020_bib0002","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.urology.2014.05.055","article-title":"Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations","volume":"84","author":"Alberts","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2025.10.020_bib0003","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.urology.2020.11.014","article-title":"Prevalence and predictors of venous thromboembolism after robot-assisted radical cystectomy","volume":"149","author":"Elsayed","year":"2021","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.020_bib0004","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.juro.2013.10.096","article-title":"Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxis","volume":"191","author":"VanDlac","year":"2014","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.10.020_bib0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.020_bib0006","unstructured":"Tikkinen K.A.O., Cartwright R., Gould M.K., et al. EAU guidelines on thromboprophylaxis in urological surgery. Accessed May 5, 2024. https:\/\/uroweb.org\/guideline\/thromboprophylaxis\/"},{"issue":"2 Suppl","key":"10.1016\/j.urolonc.2025.10.020_bib0007","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in Chest. 2012 Dec;142(6):1698\u2013704","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.urolonc.2025.10.020_bib0008","doi-asserted-by":"crossref","first-page":"849.e19","DOI":"10.1016\/j.urolonc.2020.05.030","article-title":"Practice patterns for extended venous thromboembolism chemoprophylaxis among urologic oncologists after radical cystectomy","volume":"38","author":"Dall","year":"2020","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2025.10.020_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.020_bib0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/JU.0000000000002788","article-title":"Apixaban vs enoxaparin for post-surgical extended-duration venous thromboembolic event prophylaxis: a prospective quality improvement study","volume":"208","author":"Westerman","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.10.020_bib0011","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.urology.2024.03.042","article-title":"Thromboembolic events after robotic radical cystectomy: a comparative analysis of extended and limited prophylaxis","volume":"190","author":"Rich","year":"2024","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2025.10.020_bib0012","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJMoa0810773","article-title":"Apixaban or enoxaparin for thromboprophylaxis after knee replacement","volume":"361","author":"Lassen","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.urolonc.2025.10.020_bib0013","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/bju.14906","article-title":"The role of extended venous thromboembolism prophylaxis for major urological cancer operations","volume":"124","author":"Naik","year":"2019","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.020_bib0014","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.urolonc.2025.10.020_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.urology.2019.09.047","article-title":"Trends in extended-duration venous thromboembolism prophylaxis following radical cystectomy","volume":"136","author":"Lyon","year":"2020","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.020_bib0016","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bju.12693","article-title":"Venous thromboembolism (VTE) prophylaxis and urological pelvic cancer surgery: a UK national audit","volume":"115","author":"Pridgeon","year":"2015","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.020_bib0017","doi-asserted-by":"crossref","first-page":"77.e9","DOI":"10.1016\/j.urolonc.2017.09.029","article-title":"Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy","volume":"36","author":"Schomburg","year":"2018","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.020_bib0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.juro.2016.08.090","article-title":"Extended duration enoxaparin decreases the rate of venous thromboembolic events after radical cystectomy compared to inpatient only subcutaneous heparin","volume":"197","author":"Pariser","year":"2017","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.10.020_bib0019","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/bju.16036","article-title":"Outcomes from a prospectively implemented protocol using apixaban after robotic radical cystectomy","volume":"132","author":"Rich","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.10.020_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.urology.2021.04.054","article-title":"Direct oral anticoagulants for venous thromboembolism prophylaxis following robot-assisted radical cystectomy: a retrospective feasibility study at a single academic medical center","volume":"156","author":"Ortiz","year":"2021","journal-title":"Urology"},{"issue":"16","key":"10.1016\/j.urolonc.2025.10.020_bib0021","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.10.020_bib0022","doi-asserted-by":"crossref","first-page":"489.e1","DOI":"10.1016\/j.urolonc.2023.10.009","article-title":"Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer","volume":"41","author":"D\u2019Andrea","year":"2023","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.10.020_bib0023","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00345-019-02705-x","article-title":"Perioperative venous thromboembolism prophylaxis in prostate cancer surgery","volume":"38","author":"Klaassen","year":"2020","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.10.020_bib0024","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.eururo.2017.03.008","article-title":"Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: systematic review and meta-analysis","volume":"73","author":"Tikkinen","year":"2018","journal-title":"Eur Urol"},{"issue":"23","key":"10.1016\/j.urolonc.2025.10.020_bib0025","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.urolonc.2025.10.020_bib0026","unstructured":"McKinney J. FDA approves first generics of Eliquis. U.S. Food and Drug Administration. Accessed January 10, 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-generics-eliquis."},{"key":"10.1016\/j.urolonc.2025.10.020_bib0027","doi-asserted-by":"crossref","first-page":"k831","DOI":"10.1136\/bmj.k831","article-title":"Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study","volume":"360","author":"Gupta","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.urolonc.2025.10.020_bib0028","doi-asserted-by":"crossref","first-page":"439.e9","DOI":"10.1016\/j.urolonc.2021.03.007","article-title":"Current practice patterns of society of urologic oncology members in performing inguinal lymph node staging\/therapy for penile cancer: a survey study","volume":"39","author":"Marilin","year":"2021","journal-title":"Urol Oncol"},{"issue":"21","key":"10.1016\/j.urolonc.2025.10.020_bib0029","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1001\/jama.2022.7393","article-title":"Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy on 90-day morbidity and mortality among patients with bladder cancer: a randomized clinical trial","volume":"327","author":"Catto","year":"2022","journal-title":"JAMA"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:30:34Z","timestamp":1769257834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1078143925004181"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.020","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative use of venous thromboembolism prophylaxis following major urologic oncology surgeries: A survey of the Society of Urologic Oncology","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}